Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 17, 16:00
583.80
3.1 (0.53%)
VOLUME 46,569
LIVE
NSE
Nov 17, 15:59
582.70
0.1 (0.02%)
VOLUME 552,164
Download Annual Report PDF Format 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Sep '17 Jun '17 Mar '17 Dec '16 Sep '16
Net Sales/Income from operations 1,619.55 1,510.93 1,938.56 2,114.95 2,033.97
Other Operating Income 40.26 36.85 126.53 76.83 137.47
Total Income From Operations 1,659.81 1,547.78 2,065.09 2,191.78 2,171.44
EXPENDITURE
Consumption of Raw Materials 484.82 500.02 547.88 561.53 605.82
Purchase of Traded Goods 66.41 69.31 56.03 66.15 68.85
Increase/Decrease in Stocks 58.50 -10.93 0.10 7.30 -17.86
Power & Fuel -- -- -- -- --
Employees Cost 326.43 207.77 221.13 227.41 286.81
Depreciation 28.89 29.94 27.32 26.34 25.80
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 326.20 428.68 567.85 484.99 446.59
P/L Before Other Inc. , Int., Excpt. Items & Tax 368.56 323.00 644.78 818.07 755.43
Other Income 56.30 42.59 -50.25 106.36 -5.80
P/L Before Int., Excpt. Items & Tax 424.87 365.59 594.53 924.43 749.63
Interest 47.44 45.74 49.72 49.54 42.31
P/L Before Exceptional Items & Tax 377.43 319.85 544.81 874.89 707.33
Exceptional Items -- -- -236.45 -- --
P/L Before Tax 377.43 319.85 308.36 874.89 707.33
Tax 49.55 49.01 -48.70 163.58 151.50
P/L After Tax from Ordinary Activities 327.88 270.84 357.06 711.31 555.83
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 327.88 270.84 357.06 711.31 555.83
Equity Share Capital 28.22 28.22 28.22 28.22 28.22
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 11.62 9.60 12.65 25.21 19.70
Diluted EPS 11.62 9.60 12.65 25.20 19.70
EPS After Extra Ordinary
Basic EPS 11.62 9.60 12.65 25.21 19.70
Diluted EPS 11.62 9.60 12.65 25.20 19.70
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for glenmarkpharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.